Inclusion Criteria:
  -  Grade IV Glioblastoma, receiving chemotherapy with or without TTfields.
  -  Progressive or recurrent disease requiring second line treatment
  -  evidence of progression of disease by brain MRI and are planned to receive chemotherapy
Exclusion Criteria:
  -  Current use of another beta blocker that cannot be switched to carvedilol at the onset of the trial.
  -  Systolic blood pressure <90 mmHg and/or heart rate <60 bpm without hypertensive medications
  -  Allergy to beta blockers
  -  Severe or uncontrolled asthma or COPD (chronic obstructive pulmonary disease)